Crohn´s Disease Clinical Trial
Official title:
GIANT - A Multicenter, Prospective, Observational Study of Real-world Anti-TNFa Treatment Regimens of Hyrimoz™ (Adalimumab Biosimilar) or Zessly™ (Infliximab Biosimilar) in Patients With Crohn's Disease
Hyrimoz™ was developed as a biosimilar to HumiraTM (INN: adalimumab) and Zessly™ was
developed as a biosimilar to RemicadeTM (INN: infliximab). Within the Biosimilar Development
Program of Hyrimoz™ and Zessly™, two clinical confirmatory efficacy and safety studies were
conducted: Hyrimoz™ in plaque psoriasis and Zessly™ in rheumatoid arthritis. Both
confirmatory Phase III studies demonstrated equivalent efficacy and similar safety and
immunogenicity of Hyrimoz™ to HumiraTM and Zessly™ to RemicadeTM, respectively.
The current study is designed to provide a systematic and consistent overview of the
real-world data in biologic-naïve patients with moderate-to-severe Crohn's disease (CD). The
data collected in this observational trial will be used to increase the knowledge of the
effectiveness of Hyrimoz™ and Zessly™ in clinical routine care in patients with
moderate-to-severe CD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
| Completed |
NCT01102855 -
Endomicroscopy and Crohn´s Disease
|
N/A | |
| Completed |
NCT01279577 -
Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
|
Phase 2 | |
| Completed |
NCT01086553 -
9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
|
Phase 3 | |
| Completed |
NCT02763293 -
Osteopathy Non-manipulative in Patients With Crohn's Disease.
|
N/A | |
| Completed |
NCT01289366 -
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
|
N/A | |
| Recruiting |
NCT06006039 -
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
|
||
| Completed |
NCT03890445 -
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
|
||
| Completed |
NCT01564823 -
Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
|
Phase 3 | |
| Completed |
NCT01768858 -
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
|
||
| Completed |
NCT01417702 -
Endoscopy for Assessment of Mucosal Healing in IBD
|
||
| Completed |
NCT01417715 -
Endomicroscopy for Assessment of Mucosal Healing
|
||
| Terminated |
NCT00862121 -
A Study With Pentasa in Patients With Active Crohn's Disease
|
Phase 3 |